FDA 510(k) Clearance for ARROW FlexBlock

The ARROW FlexBlock continuous peripheral nerve block catheter from Teleflex Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

The ARROW FlexBlock continuous peripheral nerve block catheter is for clinicians who use ultrasound-guidance when placing continuous peripheral nerve block catheters. Construction of the echogenic, coil-reinforced FlexBlock catheter body is of polyurethane, and the unique catheter design offers a combination of ultrasound visibility, flexibility, and excellent kink resistance. The FlexBlock catheter’s tip design looks to provide clinicians with a predictable spread of anesthetic.

"Teleflex is pleased to be adding the ARROW FlexBlock catheter to our market-leading1 line of ARROW StimuCath continuous peripheral nerve block catheters,” states Cary Vance, president, Teleflex Anesthesia and Respiratory. “These products, in addition to the StimuQuik ECHO peripheral nerve block needles, SureBlock spinal trays, and the recently 510(k) cleared FlexTip Plus Multi-Port epidural catheters, give Teleflex a clinically differentiated regional anesthesia product portfolio, designed to meet the needs of anesthesiologists in the field of regional anesthesia and acute pain management.”